nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—colon cancer	0.563	1	CbGaD
Phenylbutazone—SLC22A11—Methotrexate—colon cancer	0.108	0.305	CbGbCtD
Phenylbutazone—SLC22A8—Methotrexate—colon cancer	0.0628	0.178	CbGbCtD
Phenylbutazone—CYP2C9—Capecitabine—colon cancer	0.0614	0.174	CbGbCtD
Phenylbutazone—SLC22A6—Methotrexate—colon cancer	0.0437	0.124	CbGbCtD
Phenylbutazone—CYP2C9—Fluorouracil—colon cancer	0.0364	0.103	CbGbCtD
Phenylbutazone—CYP3A4—Irinotecan—colon cancer	0.0221	0.0624	CbGbCtD
Phenylbutazone—CYP3A4—Vincristine—colon cancer	0.0193	0.0545	CbGbCtD
Phenylbutazone—PTGIS—endothelium—colon cancer	0.0117	0.153	CbGeAlD
Phenylbutazone—PTGIS—blood vessel—colon cancer	0.0108	0.141	CbGeAlD
Phenylbutazone—PTGIS—gall bladder—colon cancer	0.0102	0.132	CbGeAlD
Phenylbutazone—PTGIS—smooth muscle tissue—colon cancer	0.00507	0.066	CbGeAlD
Phenylbutazone—PTGIS—liver—colon cancer	0.00299	0.0388	CbGeAlD
Phenylbutazone—SLC22A11—renal system—colon cancer	0.00273	0.0355	CbGeAlD
Phenylbutazone—PTGIS—lymph node—colon cancer	0.00229	0.0298	CbGeAlD
Phenylbutazone—SLC22A11—digestive system—colon cancer	0.00224	0.0292	CbGeAlD
Phenylbutazone—PTGS1—endothelium—colon cancer	0.0022	0.0286	CbGeAlD
Phenylbutazone—PTGS2—endothelium—colon cancer	0.0021	0.0273	CbGeAlD
Phenylbutazone—PTGS1—blood vessel—colon cancer	0.00203	0.0264	CbGeAlD
Phenylbutazone—PTGS2—blood vessel—colon cancer	0.00194	0.0252	CbGeAlD
Phenylbutazone—PTGS2—gall bladder—colon cancer	0.00182	0.0237	CbGeAlD
Phenylbutazone—SLC22A11—liver—colon cancer	0.00167	0.0217	CbGeAlD
Phenylbutazone—SLC22A8—renal system—colon cancer	0.00154	0.0201	CbGeAlD
Phenylbutazone—PTGS2—embryo—colon cancer	0.00116	0.015	CbGeAlD
Phenylbutazone—PTGS1—epithelium—colon cancer	0.000987	0.0128	CbGeAlD
Phenylbutazone—PTGS1—smooth muscle tissue—colon cancer	0.000951	0.0124	CbGeAlD
Phenylbutazone—PTGS2—epithelium—colon cancer	0.000943	0.0123	CbGeAlD
Phenylbutazone—PTGS1—renal system—colon cancer	0.000915	0.0119	CbGeAlD
Phenylbutazone—PTGS2—smooth muscle tissue—colon cancer	0.000909	0.0118	CbGeAlD
Phenylbutazone—PTGS2—renal system—colon cancer	0.000875	0.0114	CbGeAlD
Phenylbutazone—CYP2C9—digestive system—colon cancer	0.000822	0.0107	CbGeAlD
Phenylbutazone—CYP3A4—renal system—colon cancer	0.000765	0.00994	CbGeAlD
Phenylbutazone—PTGS1—digestive system—colon cancer	0.000751	0.00976	CbGeAlD
Phenylbutazone—PTGS2—lymphoid tissue—colon cancer	0.000727	0.00945	CbGeAlD
Phenylbutazone—PTGS2—digestive system—colon cancer	0.000718	0.00933	CbGeAlD
Phenylbutazone—PTGS1—vagina—colon cancer	0.000663	0.00862	CbGeAlD
Phenylbutazone—PTGS2—bone marrow—colon cancer	0.000662	0.0086	CbGeAlD
Phenylbutazone—PTGS2—vagina—colon cancer	0.000634	0.00824	CbGeAlD
Phenylbutazone—CYP3A4—digestive system—colon cancer	0.000627	0.00815	CbGeAlD
Phenylbutazone—Oxaprozin—PTGS2—colon cancer	0.000622	0.238	CrCbGaD
Phenylbutazone—CYP2C9—liver—colon cancer	0.000613	0.00797	CbGeAlD
Phenylbutazone—PTGIS—Nicotinamide salvaging—PTGS2—colon cancer	0.000565	0.138	CbGpPWpGaD
Phenylbutazone—Protriptyline—ABCB1—colon cancer	0.000537	0.206	CrCbGaD
Phenylbutazone—PTGS2—liver—colon cancer	0.000535	0.00695	CbGeAlD
Phenylbutazone—Sulfinpyrazone—ABCB1—colon cancer	0.000491	0.188	CrCbGaD
Phenylbutazone—CYP3A4—liver—colon cancer	0.000467	0.00607	CbGeAlD
Phenylbutazone—PTGS1—lymph node—colon cancer	0.000429	0.00558	CbGeAlD
Phenylbutazone—PTGS2—lymph node—colon cancer	0.00041	0.00533	CbGeAlD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—colon cancer	0.000301	0.0736	CbGpPWpGaD
Phenylbutazone—Fentanyl—ABCB1—colon cancer	0.000268	0.103	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—colon cancer	0.000266	0.102	CrCbGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—colon cancer	0.000248	0.0607	CbGpPWpGaD
Phenylbutazone—Phenytoin—ABCB1—colon cancer	0.000243	0.093	CrCbGaD
Phenylbutazone—Methadone—ABCB1—colon cancer	0.000184	0.0704	CrCbGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—colon cancer	0.000161	0.0395	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000135	0.033	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—BAX—colon cancer	0.000103	0.0253	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—colon cancer	8.95e-05	0.0219	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—BAX—colon cancer	8.19e-05	0.0201	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	8e-05	0.0196	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—colon cancer	7.62e-05	0.0187	CbGpPWpGaD
Phenylbutazone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	7.55e-05	0.0185	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CA7—colon cancer	6.5e-05	0.0159	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	5.97e-05	0.0146	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	5.75e-05	0.0141	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—PPARG—colon cancer	5.3e-05	0.013	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	5.27e-05	0.0129	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	4.95e-05	0.0121	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LGR5—colon cancer	4.7e-05	0.0115	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CHST5—colon cancer	4.7e-05	0.0115	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	4.28e-05	0.0105	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	4.14e-05	0.0101	CbGpPWpGaD
Phenylbutazone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	4.13e-05	0.0101	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CHST5—colon cancer	3.94e-05	0.00965	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ODC1—colon cancer	3.94e-05	0.00965	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	3.81e-05	0.00934	CbGpPWpGaD
Phenylbutazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	3.78e-05	0.00925	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—VEGFA—colon cancer	3.73e-05	0.00914	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—CTNNB1—colon cancer	3.73e-05	0.00914	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	3.67e-05	0.00899	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—CDKN1A—colon cancer	3.64e-05	0.00893	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	3.6e-05	0.00882	CbGpPWpGaD
Phenylbutazone—CYP3A4—Irinotecan Pathway—APC—colon cancer	3.48e-05	0.00852	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AXIN2—colon cancer	3.38e-05	0.00828	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TGFB1—colon cancer	3.01e-05	0.00738	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	2.78e-05	0.0068	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	2.75e-05	0.00674	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	2.6e-05	0.00637	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.5e-05	0.00613	CbGpPWpGaD
Phenylbutazone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	2.49e-05	0.0061	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	2.42e-05	0.00593	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	2.37e-05	0.00581	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	2.19e-05	0.00536	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	2.04e-05	0.005	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	2.03e-05	0.00497	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA7—colon cancer	2e-05	0.0049	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	1.94e-05	0.00476	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	1.89e-05	0.00463	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	1.84e-05	0.00451	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	1.82e-05	0.00445	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	1.75e-05	0.00429	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.75e-05	0.00429	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	1.73e-05	0.00424	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	1.69e-05	0.00415	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	1.66e-05	0.00405	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	1.65e-05	0.00404	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.63e-05	0.00398	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA7—colon cancer	1.59e-05	0.00389	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	1.56e-05	0.00383	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	1.45e-05	0.00354	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	1.37e-05	0.00335	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.34e-05	0.00329	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.33e-05	0.00326	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCB1—colon cancer	1.33e-05	0.00325	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	1.3e-05	0.00319	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.29e-05	0.00317	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.28e-05	0.00313	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	1.26e-05	0.00309	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CHST5—colon cancer	1.21e-05	0.00297	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ODC1—colon cancer	1.21e-05	0.00297	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—EP300—colon cancer	1.2e-05	0.00294	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CHST5—colon cancer	1.15e-05	0.00281	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LGR5—colon cancer	1.15e-05	0.00281	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	1.12e-05	0.00275	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.06e-05	0.00261	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA7—colon cancer	1.05e-05	0.00257	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MYC—colon cancer	1.05e-05	0.00256	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ABCB1—colon cancer	1.04e-05	0.00255	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—TYMS—colon cancer	1.02e-05	0.0025	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CASP3—colon cancer	1.02e-05	0.0025	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCB1—colon cancer	1.01e-05	0.00248	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCND1—colon cancer	9.93e-06	0.00243	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.85e-06	0.00241	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGFR3—colon cancer	9.76e-06	0.00239	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	9.66e-06	0.00237	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ODC1—colon cancer	9.61e-06	0.00235	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CHST5—colon cancer	9.61e-06	0.00235	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APC—colon cancer	8.96e-06	0.0022	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	8.44e-06	0.00207	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BRAF—colon cancer	8.42e-06	0.00206	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AXIN2—colon cancer	8.25e-06	0.00202	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	8.21e-06	0.00201	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MYC—colon cancer	7.97e-06	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	7.95e-06	0.00195	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.87e-06	0.00193	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—EGFR—colon cancer	7.79e-06	0.00191	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PPARG—colon cancer	7.24e-06	0.00177	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.94e-06	0.0017	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA7—colon cancer	6.93e-06	0.0017	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—colon cancer	6.8e-06	0.00167	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.76e-06	0.00165	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.69e-06	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—colon cancer	6.54e-06	0.0016	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.53e-06	0.0016	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CHST5—colon cancer	6.37e-06	0.00156	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ODC1—colon cancer	6.37e-06	0.00156	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.22e-06	0.00152	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—colon cancer	6.09e-06	0.00149	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.05e-06	0.00148	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1A—colon cancer	5.95e-06	0.00146	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.89e-06	0.00144	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—colon cancer	5.7e-06	0.0014	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EP300—colon cancer	5.66e-06	0.00139	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SRC—colon cancer	5.5e-06	0.00135	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.42e-06	0.00133	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.41e-06	0.00132	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.3e-06	0.0013	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NRAS—colon cancer	5.29e-06	0.0013	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.01e-06	0.00123	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5e-06	0.00122	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—colon cancer	4.93e-06	0.00121	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFB1—colon cancer	4.92e-06	0.0012	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—colon cancer	4.82e-06	0.00118	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—EP300—colon cancer	4.74e-06	0.00116	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.6e-06	0.00113	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—colon cancer	4.56e-06	0.00112	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.45e-06	0.00109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CHST5—colon cancer	4.2e-06	0.00103	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ODC1—colon cancer	4.2e-06	0.00103	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—colon cancer	4.19e-06	0.00103	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.97e-06	0.000972	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.93e-06	0.000963	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HRAS—colon cancer	3.87e-06	0.000949	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.76e-06	0.00092	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—colon cancer	3.51e-06	0.000859	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—colon cancer	3.42e-06	0.000838	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.27e-06	0.000801	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—colon cancer	3.2e-06	0.000784	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TYMS—colon cancer	3.14e-06	0.00077	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—colon cancer	2.86e-06	0.000702	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.63e-06	0.000644	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.6e-06	0.000636	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—colon cancer	2.54e-06	0.000622	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TYMS—colon cancer	2.5e-06	0.000611	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.42e-06	0.000593	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGFR3—colon cancer	2.38e-06	0.000583	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—colon cancer	2.23e-06	0.000545	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—colon cancer	2.19e-06	0.000536	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.07e-06	0.000506	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BRAF—colon cancer	2.06e-06	0.000503	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.92e-06	0.000471	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—colon cancer	1.77e-06	0.000433	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—colon cancer	1.75e-06	0.000429	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.72e-06	0.000421	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—colon cancer	1.68e-06	0.000412	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TYMS—colon cancer	1.65e-06	0.000405	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—colon cancer	1.49e-06	0.000364	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—EP300—colon cancer	1.46e-06	0.000357	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1A—colon cancer	1.45e-06	0.000355	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EP300—colon cancer	1.38e-06	0.000338	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SRC—colon cancer	1.34e-06	0.000329	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NRAS—colon cancer	1.29e-06	0.000316	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.27e-06	0.000312	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—colon cancer	1.2e-06	0.000295	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—colon cancer	1.2e-06	0.000294	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—colon cancer	1.18e-06	0.000288	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—colon cancer	1.17e-06	0.000287	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—EP300—colon cancer	1.16e-06	0.000283	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—colon cancer	1.11e-06	0.000272	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—colon cancer	1.11e-06	0.000272	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TYMS—colon cancer	1.09e-06	0.000267	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—colon cancer	1.08e-06	0.000264	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—colon cancer	1.02e-06	0.00025	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HRAS—colon cancer	9.45e-07	0.000231	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—colon cancer	9.21e-07	0.000226	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—colon cancer	8.8e-07	0.000216	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—colon cancer	8.55e-07	0.00021	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—colon cancer	8.34e-07	0.000204	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—colon cancer	7.72e-07	0.000189	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—EP300—colon cancer	7.66e-07	0.000188	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—colon cancer	6.99e-07	0.000171	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—colon cancer	6.07e-07	0.000149	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—colon cancer	5.66e-07	0.000139	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—EP300—colon cancer	5.05e-07	0.000124	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—colon cancer	4.63e-07	0.000113	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—colon cancer	3.74e-07	9.15e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—colon cancer	3.05e-07	7.48e-05	CbGpPWpGaD
